SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is currently seeing heightened community debate following an officially scheduled reverse stock split, with retail investors questioning the company's valuation and long-term viability in the competitive streaming sector. While some participants anticipate a short squeeze or a potential rebound on the low float, many are voicing frustration over management's performance and the lack of clear, actionable catalysts to drive a meaningful recovery.

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.

Karyopharm Therapeutics Inc

Karyopharm Therapeutics is experiencing significant market activity following the announcement of a 30 million dollar private placement with RA Capital, alongside positive top-line data from its Phase 3 SENTRY trial which met its primary endpoint for spleen volume reduction in myelofibrosis patients. While the company's stock is seeing extreme volatility and high volume, community sentiment remains sharply divided as investors debate the potential for future regulatory approval, the impact of the financing on dilution, and ongoing concerns regarding the company's financial runway.

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

The meme coin SPERMWHALE is attracting attention from speculative traders due to its rapid, high-percentage price moves and low market capitalization, sparking intense debate over whether it represents a legitimate growth opportunity or a classic pump-and-dump scheme. While proponents highlight early accumulation patterns and potential for massive gains, critics emphasize the high concentration of supply among top holders and the lack of fundamental utility, urging others to be cautious of potential rug pulls.

Cantor Equity Partners II, Inc. is a blank check company. The company was founded on November 11, 2020 and is headquartered in New York, NY

Cantor Equity Partners II Inc. - Ordinary Shares - Class A

Cantor Equity Partners II Inc

Investors are closely monitoring CEPT as it approaches its merger with Securitize, a leading infrastructure provider in the rapidly expanding real-world asset tokenization space. The community is actively debating the stock's potential as a pure-play opportunity, highlighting strong institutional backing from major firms like BlackRock and recent positive reports from analyst research firms.

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

AleAnna Inc. is seeing intense investor focus as geopolitical instability in the Middle East disrupts global LNG supplies, positioning the company as a key supplier for energy-dependent European markets. The community is actively debating the stock's potential for a short squeeze amid high borrow rates and low float, while closely monitoring technical price action and potential energy infrastructure developments.

Li Auto, Inc. engages in the design, development, manufacture, and sale of premium smart electric vehicles. Its products include Li MEGA, a high-tech flagship family MPV, Li L9, a six-seat flagship family SUV, and Li L8, a six-seat premium family SUV, and Li L7, a five-seat flagship family SUV. The firm also offers in-house development efforts on its proprietary range extension system, next-generation electric vehicle technology, and smart vehicle solutions. The company was founded by Xiang Li in April 2015 and is headquartered in Beijing, China.

Li Auto Inc - ADR

Li Auto is trending as investors react to the company's newly authorized $1 billion share repurchase program, which will be valid through March 2027. While some market participants interpret the buyback as a sign of management's confidence and a potential boost to earnings per share, others remain focused on the company's valuation struggles, intense competition in the Chinese EV market, and ongoing debates regarding the efficacy of its charging technology compared to battery-swapping alternatives.

Concentrix Corp. engages in the provision of customer experience solutions and technology. The company was founded in 1973 and is headquartered in Newark, CA.

Concentrix Corp.

Concentrix Corporation

Concentrix is seeing intense investor focus as the stock reacts to mixed Q1 results and the announced $4.8 billion merger with Webhelp. While the community is actively debating the implications of the deal on long-term growth and debt levels, traders are closely tracking the stock's volatility and its potential to capture synergy-driven value.

Core & Main, Inc. is a specialty distributor focused on water, wastewater, storm drainage and fire protection products, and related services. The company provides infrastructure solutions to municipalities, private water companies and professional contractors across municipal, non-residential, and residential end markets, nationwide. The company was founded in 1874 and is headquartered in St. Louis, MO.

Core & Main Inc - Ordinary Shares Class A

Core & Main Inc

Core & Main is seeing active engagement as investors digest the company's latest quarterly earnings, which showed solid sales growth and raised full-year guidance despite broader macroeconomic headwinds. The community is focused on the firm's acquisition-heavy growth strategy and its role as a key player in U.S. water infrastructure, with many debating the impact of ongoing share repurchases on long-term value.

Hesai Group engages in the development, manufacture and sale of three-dimensional light detection and ranging(lidar) solutions. The company’s lidar products enable a broad spectrum of applications across passenger and commercial vehicles with advanced driver assistance systems (ADAS) and autonomous vehicle fleets. The company was founded by Yi Fan Li, Kai Sun, and Shao Qing Xiang in October 2014 and is headquartered in Shanghai, China.

Hesai Group - ADR

Hesai Group is trending following strong Q4 financial results that revealed full-year non-GAAP profitability and a significant increase in lidar shipments. The community is actively discussing the stock's growth trajectory, its strategic design wins with major OEMs like BYD and Mercedes-Benz, and ongoing debates regarding the company's competitive position against Western lidar firms amidst geopolitical scrutiny.

Apollo Global Management, Inc. provides asset management services. It offers its clients excess return at every point along the risk-reward spectrum from investment grade to private equity with a focus on three business strategies: yield, hybrid, and equity. It operates through following segments: Asset Management, Retirement Services and Principal Investing. The Asset Management segment focuses on credit and equity investing strategies. The Retirement Services and Principal Investing segment consists of realized performance fee income, realized investment income from balance sheet investments, and certain allocable expenses related to corporate functions supporting the entire company. The company was founded by Marc Rowan in 1990 and is headquartered in New York, NY.

Apollo Global Management Inc

Apollo Global Management is experiencing heightened market attention following reports that CEO Marc Rowan is a key contender for U.S. Treasury Secretary, a development that has fueled investor optimism regarding the potential for deregulation. Meanwhile, the stock continues to benefit from institutional interest and strong earnings momentum that has bolstered its status as a major player in private markets and credit.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Biofrontera (BFRI) Q4 2025 Earnings Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

Are Medical Stocks Lagging  Align Technology (ALGN) This Year?

Here is how Align Technology (ALGN) and Biofrontera Inc. (BFRI) have performed compared to their sector so far this year.

Biofrontera Inc. (BFRI) Upgraded to Buy: Here's Why

Biofrontera Inc. (BFRI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Biofrontera Inc. (BFRI) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Biofrontera Inc. (BFRI) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Is Biofrontera Inc. (BFRI) Stock Outpacing Its Medical Peers This Year?

Here is how Biofrontera Inc. (BFRI) and Brookdale Senior Living (BKD) have performed compared to their sector so far this year.

Biofrontera Earnings Preview

Roivant Sciences Ltd. (ROIV) Reports Q2 Loss, Lags Revenue Estimates

Montes Archimedes Acquisition (ROIV) delivered earnings and revenue surprises of -3.70% and -75.13%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Lifecore Biomedical (LFCR) Reports Q1 Loss, Beats Revenue Estimates

Lifecore Biomedical (LFCR) delivered earnings and revenue surprises of +3.33% and +16.60%, respectively, for the quarter ended August 2025. Do the numbers hold clues to what lies ahead for the stock?

Viridian Therapeutics, Inc. (VRDN) Reports Q3 Loss, Tops Revenue Estimates

Viridian Therapeutics (VRDN) delivered earnings and revenue surprises of +58.54% and +50.85%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

PTC Therapeutics (PTCT) Q3 Earnings and Revenues Top Estimates

PTC Therapeutics (PTCT) delivered earnings and revenue surprises of +116.81% and +20.17%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Biofrontera, Inc. is a biopharmaceutical company, which engages in the commercialization of pharmaceutical products. It specializes in the treatment of dermatological conditions, caused primarily by exposure to sunlight that results in sun damage to the skin. The company focuses on the treatment of actinic keratosis and markets a topical antibiotic for treatment of impetigo. Its products include Ameluz and Xepi, its two prescription drugs, and BF-RhodoLED, a lamp used with Ameluz, for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company was founded on March 3, 2015 and is headquartered in Woburn, MA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.12	--	--	N/A
Q4 '25	$0.19	--	--	N/A
Q3 '25	-$0.58	-$0.62	-6.90%	MISSED
Q2 '25	-$0.42	-$0.57	-35.71%	MISSED
Q1 '25	-$0.22	-$0.47	-118.60%	MISSED

BFRI
Biofrontera Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest BFRI News

BFRIBiofrontera Inc